Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus

British Journal of Biomedical Science

Volumn 63, Issue 4, 2006, Pages 171-173

  Lotfy, Mahmoud ^a   Badra, G ^a   Burham, W ^b   Alenzi, F Q ^c  

^a MENOUFIA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ASCORBIC ACID; CALCIUM CARBONATE; CIPROFLOXACIN; COMMIPHORA MOLMOL EXTRACT; GATIFLOXACIN; INSULIN; MATRIX METALLOPROTEINASE; METRONIDAZOLE; PENTOXIFYLLINE; PLANT EXTRACT; PROPOLIS; RETINOL; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; ZINC;

ADD ON THERAPY; AGED; ALTERNATIVE MEDICINE; ANAMNESIS; ARTICLE; CASE REPORT; COMMIPHORA; DIABETES MELLITUS; DIABETIC FOOT; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; HONEY; HUMAN; INFECTION; INFLAMMATION; MALE; PRIORITY JOURNAL; WOUND CARE; WOUND HEALING; WOUND INFECTION;

APIS MELLIFERA; COMMIPHORA;

EID: 33845944797     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2006.11732742     Document Type: Article

References (34)

1. Mancini L, Ruotolo V. The diabetic foot: epidemiology. Rays 1997; 22: 511-23.
2. Bloomgarden ZT. Diabetes complications. Diabetes Care 2004; 27: 1506-14.
3. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998; 111: 850-7.
4. Jude EB, Blakytny R, Bulmer J, Boulton AJ, Ferguson MW. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med 2002; 19: 440-7.
5. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-6.
6. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 2000; 190: 589-94.
7. Bouter KE Storm AJ, de Groot RRM et al. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. Eur J Med 1993; 2: 215-8.
8. Pecoraro RE, Ahroni JH, Bpyko EJ et al. Chronology and extremities of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991; 40: 1305-13.
9. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 1991; 22: 1354-60.
10. McInnes A. Guide to the assessment and management of diabetic foot wounds. The Diabetic Foot 200; 4 (Suppl 1): SI-II.
11. Ikes RS, Wolfe JHN. The diabetic foot. BMJ 1991; 303: 1053-5.
12. Hall BL, Oser BL. Recent progress in the consideration of flavoring ingredients under the food additive amendment. 3. GRAF substances. Food Technol 1965; 19: 151-97.
13. Ford RA, Api AM, Letizia CS. Monographs on fragrance to raw materials. Food Chem Toxicol 1992; 30 (Suppl): 91S-92S.
14. Al Harbi MM, Qureshi S, Ahmed MM, Rafatulla S, Shah AH. Effect of Commiphora molmol (oleogum resin) on the cytological and biochemical changes induced by cyclophosphamide in mice. Am J Chin Med 1994; 22: 77-82.
15. Botros S, Sayed H, El-Dusoki H et al. Efficacy of Mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg 2005; 72 (2): 119-23.
16. Sheir Z, Nasr AA, Massoud A et al. A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg 2001; 65: 700-4.
17. El Ashry ES, Rashed N, Salama OM, Saleh A. Components, therapeutic value and uses of myrrh. Pharmazie 2003; 58 (3): 163-8.
18. Dolara P, Corte B, Ghelardini C et al. A. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000; 66 (4): 356-8.
19. Al-Awadi F, Fatania H, Shamte U. The effect of a plant mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res 1991; 18 (4): 163-8.
20. Michie CA, Cooper E. Frankincense and myrrh as remedies in children. J R Soc Med. 1991; 84: 602-5.
21. Lotfy M. Biological activity of bee propolis in health and disease. Asian Pac J Cancer Prev 2006; 7: 22-31.
22. Fernandes Júnior A, Balestrin ECC, Cunha MLRS. Anti-Staphylococcus aureus activity of bee propolis extracts prepared with different ethanol concentrations. Rev Ciênc Farm 2003; 24: 147-52.
23. Fernandes Júnior A, Leomil L, Fernandes AAH, Sforcin JM. The antibacterial activity of propolis produced by Apis mellifera L. and Brazilian stingless bees. J Venom Anim Toxins 2001; 7: 173-82.
24. Bosio K, Avanzini C, D'avolio A, Ozimo O, Savoia D. In vitro activity of propolis against Streptococcus pyogenes. Lett Appl Microbiol 2000; 31: 174-7.
25. Drago I, Mombelli B, De Vecchi E, Fassina MC, Tocalli L, Gismondo MR. In vitro antimicrobial activity of propolis dry extract. J Chemotherapy 2002; 12: 390-5.
26. Stepanovic S, Antic N, Dakic I, Svabic-Vlahovic M. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol Res 2003; 158: 353-7.
27. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH. Effects of compounds found in propolis on Streptococcus mutans growth and on glucosiltransferase activity. Antimicrob Agents Chemother 2002; 46: 1302-9.
28. Santos FA, Bastos EMA, Uzeda B, Carvalho MAR, Farias ESA, Braga FC. Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J Ethnopharmacol 2002; 80: 1-7.
29. Orsi RO, Sforcin JM, Rall VLM, Funari SRC, Barbosa L, Fernandes Júnior A. Susceptibility profile of Salmonella against the antibacterial activity of propolis produced in two regions of Brazil. J Venom Anim Toxins 2005; 11: 109-16.
30. Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res 2001; 15: 561-71.
31. Scheller S, Dworniczak S, Waldemar KK, Rajca M, Tomczik A, Shani J. Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria. Z Naturforsch C 1999; 54: 549-53.
32. Fernandes Júnior A, Balestrin EC, Betoni JEC, Orsi RO, Cunha MLRS, Montelli AC. Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst Oswalde Cruz, Rio de Janeiro 2005; 100: 563-6.
33. Molan PC. The role of honey in the management of wounds. J Wound Care 1999; 8: 415-8.
34. Cooper RA, Molan PC. Honey in wound care. J Wound Care 1999; 8: 340.